Specialty differences in prescribing inhaled corticosteroids for children

Michael D. Cabana, Heba Abu-Isa, Shannon M. Thyne, Barbara Yawn

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Prescription of daily inhaled corticosteroids for children with persistent asthma is infrequent compared with national practice guidelines. The authors conducted a national, cross-sectional survey of pediatricians and family physicians to identify specialty differences and factors associated with physician nonadherence to National Heart, Lung, and Blood Institute guidelines for prescribing inhaled corticosteroids. Adherence was defined as following the recommendation for >90% of cases. Response rate was 49% (343/694). Pediatrician and family physicians reported similar rates of adherence (54% vs 51%). Pediatricians and family physicians reported different barriers. Although both groups indicated that parent hesitancy and nonadherence were common barriers, the most common barrier for family physicians was a perceived cost of the asthma medications for families. Pediatricians were more likely to indicate that lack of time (21% vs 10%) was a barrier to prescribing inhaled corticosteroids. In multivariate logistic analysis, the lack of a family/practice barrier (odds ratio, 0.27; 95% confidence interval, 0.13, 0.55) and physician agreement with the National Heart, Lung, and Blood Institute recommendation (odds ratio, 4.21; 95% confidence interval, 1.43, 12.3) was associated with self-reported adherence. Interventions to improve prescribing of inhaled corticosteroids should include strategies to address issues specific to pediatricians and family physicians.

Original languageEnglish (US)
Pages (from-to)698-705
Number of pages8
JournalClinical Pediatrics
Volume46
Issue number8
DOIs
StatePublished - Oct 1 2007
Externally publishedYes

Fingerprint

Family Physicians
Adrenal Cortex Hormones
National Heart, Lung, and Blood Institute (U.S.)
Asthma
Odds Ratio
Confidence Intervals
Physicians
Family Practice
Practice Guidelines
Prescriptions
Multivariate Analysis
Cross-Sectional Studies
Pediatricians
Guidelines
Costs and Cost Analysis

Keywords

  • Physician training
  • Practice management
  • Quality improvement

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Specialty differences in prescribing inhaled corticosteroids for children. / Cabana, Michael D.; Abu-Isa, Heba; Thyne, Shannon M.; Yawn, Barbara.

In: Clinical Pediatrics, Vol. 46, No. 8, 01.10.2007, p. 698-705.

Research output: Contribution to journalArticle

Cabana, Michael D. ; Abu-Isa, Heba ; Thyne, Shannon M. ; Yawn, Barbara. / Specialty differences in prescribing inhaled corticosteroids for children. In: Clinical Pediatrics. 2007 ; Vol. 46, No. 8. pp. 698-705.
@article{27c59d831b78438fb5d9b896d37811cd,
title = "Specialty differences in prescribing inhaled corticosteroids for children",
abstract = "Prescription of daily inhaled corticosteroids for children with persistent asthma is infrequent compared with national practice guidelines. The authors conducted a national, cross-sectional survey of pediatricians and family physicians to identify specialty differences and factors associated with physician nonadherence to National Heart, Lung, and Blood Institute guidelines for prescribing inhaled corticosteroids. Adherence was defined as following the recommendation for >90{\%} of cases. Response rate was 49{\%} (343/694). Pediatrician and family physicians reported similar rates of adherence (54{\%} vs 51{\%}). Pediatricians and family physicians reported different barriers. Although both groups indicated that parent hesitancy and nonadherence were common barriers, the most common barrier for family physicians was a perceived cost of the asthma medications for families. Pediatricians were more likely to indicate that lack of time (21{\%} vs 10{\%}) was a barrier to prescribing inhaled corticosteroids. In multivariate logistic analysis, the lack of a family/practice barrier (odds ratio, 0.27; 95{\%} confidence interval, 0.13, 0.55) and physician agreement with the National Heart, Lung, and Blood Institute recommendation (odds ratio, 4.21; 95{\%} confidence interval, 1.43, 12.3) was associated with self-reported adherence. Interventions to improve prescribing of inhaled corticosteroids should include strategies to address issues specific to pediatricians and family physicians.",
keywords = "Physician training, Practice management, Quality improvement",
author = "Cabana, {Michael D.} and Heba Abu-Isa and Thyne, {Shannon M.} and Barbara Yawn",
year = "2007",
month = "10",
day = "1",
doi = "10.1177/0009922807301436",
language = "English (US)",
volume = "46",
pages = "698--705",
journal = "Clinical Pediatrics",
issn = "0009-9228",
publisher = "SAGE Publications Inc.",
number = "8",

}

TY - JOUR

T1 - Specialty differences in prescribing inhaled corticosteroids for children

AU - Cabana, Michael D.

AU - Abu-Isa, Heba

AU - Thyne, Shannon M.

AU - Yawn, Barbara

PY - 2007/10/1

Y1 - 2007/10/1

N2 - Prescription of daily inhaled corticosteroids for children with persistent asthma is infrequent compared with national practice guidelines. The authors conducted a national, cross-sectional survey of pediatricians and family physicians to identify specialty differences and factors associated with physician nonadherence to National Heart, Lung, and Blood Institute guidelines for prescribing inhaled corticosteroids. Adherence was defined as following the recommendation for >90% of cases. Response rate was 49% (343/694). Pediatrician and family physicians reported similar rates of adherence (54% vs 51%). Pediatricians and family physicians reported different barriers. Although both groups indicated that parent hesitancy and nonadherence were common barriers, the most common barrier for family physicians was a perceived cost of the asthma medications for families. Pediatricians were more likely to indicate that lack of time (21% vs 10%) was a barrier to prescribing inhaled corticosteroids. In multivariate logistic analysis, the lack of a family/practice barrier (odds ratio, 0.27; 95% confidence interval, 0.13, 0.55) and physician agreement with the National Heart, Lung, and Blood Institute recommendation (odds ratio, 4.21; 95% confidence interval, 1.43, 12.3) was associated with self-reported adherence. Interventions to improve prescribing of inhaled corticosteroids should include strategies to address issues specific to pediatricians and family physicians.

AB - Prescription of daily inhaled corticosteroids for children with persistent asthma is infrequent compared with national practice guidelines. The authors conducted a national, cross-sectional survey of pediatricians and family physicians to identify specialty differences and factors associated with physician nonadherence to National Heart, Lung, and Blood Institute guidelines for prescribing inhaled corticosteroids. Adherence was defined as following the recommendation for >90% of cases. Response rate was 49% (343/694). Pediatrician and family physicians reported similar rates of adherence (54% vs 51%). Pediatricians and family physicians reported different barriers. Although both groups indicated that parent hesitancy and nonadherence were common barriers, the most common barrier for family physicians was a perceived cost of the asthma medications for families. Pediatricians were more likely to indicate that lack of time (21% vs 10%) was a barrier to prescribing inhaled corticosteroids. In multivariate logistic analysis, the lack of a family/practice barrier (odds ratio, 0.27; 95% confidence interval, 0.13, 0.55) and physician agreement with the National Heart, Lung, and Blood Institute recommendation (odds ratio, 4.21; 95% confidence interval, 1.43, 12.3) was associated with self-reported adherence. Interventions to improve prescribing of inhaled corticosteroids should include strategies to address issues specific to pediatricians and family physicians.

KW - Physician training

KW - Practice management

KW - Quality improvement

UR - http://www.scopus.com/inward/record.url?scp=34548441972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548441972&partnerID=8YFLogxK

U2 - 10.1177/0009922807301436

DO - 10.1177/0009922807301436

M3 - Article

C2 - 17502451

AN - SCOPUS:34548441972

VL - 46

SP - 698

EP - 705

JO - Clinical Pediatrics

JF - Clinical Pediatrics

SN - 0009-9228

IS - 8

ER -